• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:肠道微生物群对结直肠癌挥发性代谢指纹图谱的贡献

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia.

作者信息

van Vorstenbosch Robert, Cheng Hao Ran, Jonkers Daisy, Penders John, Schoon Erik, Masclee Ad, van Schooten Frederik-Jan, Smolinska Agnieszka, Mujagic Zlatan

机构信息

Department of Pharmacology and Toxicology, Maastricht University, 6227 AP Maastricht, The Netherlands.

NUTRIM, School of Nutrition & Translational Research in Metabolism, Maastricht University, 6227 AP Maastricht, The Netherlands.

出版信息

Metabolites. 2022 Dec 30;13(1):55. doi: 10.3390/metabo13010055.

DOI:10.3390/metabo13010055
PMID:36676980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9865897/
Abstract

Colorectal cancer (CRC) has been associated with changes in volatile metabolic profiles in several human biological matrices. This enables its non-invasive detection, but the origin of these volatile organic compounds (VOCs) and their relation to the gut microbiome are not yet fully understood. This systematic review provides an overview of the current understanding of this topic. A systematic search using PubMed, Embase, Medline, Cochrane Library, and the Web of Science according to PRISMA guidelines resulted in seventy-one included studies. In addition, a systematic search was conducted that identified five systematic reviews from which CRC-associated gut microbiota data were extracted. The included studies analyzed VOCs in feces, urine, breath, blood, tissue, and saliva. Eight studies performed microbiota analysis in addition to VOC analysis. The most frequently reported dysregulations over all matrices included short-chain fatty acids, amino acids, proteolytic fermentation products, and products related to the tricarboxylic acid cycle and Warburg metabolism. Many of these dysregulations could be related to the shifts in CRC-associated microbiota, and thus the gut microbiota presumably contributes to the metabolic fingerprint of VOC in CRC. Future research involving VOCs analysis should include simultaneous gut microbiota analysis.

摘要

结直肠癌(CRC)与多种人体生物基质中挥发性代谢谱的变化有关。这使得其非侵入性检测成为可能,但这些挥发性有机化合物(VOCs)的来源及其与肠道微生物群的关系尚未完全明确。本系统综述概述了目前对该主题的理解。根据PRISMA指南,通过PubMed、Embase、Medline、Cochrane图书馆和科学网进行系统检索,最终纳入了71项研究。此外,还进行了一项系统检索,确定了5篇系统综述,并从中提取了与CRC相关的肠道微生物群数据。纳入的研究分析了粪便、尿液、呼出气体、血液、组织和唾液中的VOCs。8项研究除了进行VOC分析外,还进行了微生物群分析。在所有基质中最常报告的失调包括短链脂肪酸、氨基酸、蛋白水解发酵产物以及与三羧酸循环和瓦伯格代谢相关的产物。其中许多失调可能与CRC相关微生物群的变化有关,因此肠道微生物群可能对CRC中VOC的代谢指纹有贡献。未来涉及VOC分析的研究应包括同时进行肠道微生物群分析。

相似文献

1
Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia.系统评价:肠道微生物群对结直肠癌挥发性代谢指纹图谱的贡献
Metabolites. 2022 Dec 30;13(1):55. doi: 10.3390/metabo13010055.
2
Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.用于结直肠癌筛查的尿液挥发性有机化合物:系统评价和荟萃分析。
Eur J Cancer. 2023 Jun;186:69-82. doi: 10.1016/j.ejca.2023.03.002. Epub 2023 Mar 6.
3
Diagnostic Application of Volatile Organic Compounds as Potential Biomarkers for Detecting Digestive Neoplasia: A Systematic Review.挥发性有机化合物作为检测消化系肿瘤潜在生物标志物的诊断应用:一项系统综述
Diagnostics (Basel). 2021 Dec 9;11(12):2317. doi: 10.3390/diagnostics11122317.
4
Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?粪便挥发性有机化合物用于结直肠癌的早期检测:我们现在在哪里?
J Cancer Res Clin Oncol. 2019 Jan;145(1):223-234. doi: 10.1007/s00432-018-2821-3. Epub 2018 Dec 15.
5
Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.结直肠癌尿液挥发性有机化合物和粪便微生物组特征。
Colorectal Dis. 2019 Nov;21(11):1259-1269. doi: 10.1111/codi.14739. Epub 2019 Jul 10.
6
Volatile organic compounds as new biomarkers for colorectal cancer: a review.挥发性有机化合物作为结直肠癌的新型生物标志物:综述
Colorectal Dis. 2016 Jul;18(7):654-63. doi: 10.1111/codi.13271.
7
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
8
The roles of microbial products in the development of colorectal cancer: a review.微生物产物在结直肠癌发展中的作用:综述。
Bioengineered. 2021 Dec;12(1):720-735. doi: 10.1080/21655979.2021.1889109.
9
The interplay of the gut microbiome, bile acids, and volatile organic compounds.肠道微生物群、胆汁酸和挥发性有机化合物之间的相互作用。
Gastroenterol Res Pract. 2015;2015:398585. doi: 10.1155/2015/398585. Epub 2015 Mar 3.
10
Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.系统评价:粪便样本中的肠道微生物群与结直肠肿瘤的检测。
Gut Microbes. 2018 Jul 4;9(4):293-307. doi: 10.1080/19490976.2018.1445957. Epub 2018 May 15.

引用本文的文献

1
Gut microbiota interplay with autophagy-EMT dynamics in colorectal cancer.肠道微生物群与结直肠癌中的自噬-上皮-间质转化动态相互作用。
Front Cell Dev Biol. 2025 Aug 21;13:1608248. doi: 10.3389/fcell.2025.1608248. eCollection 2025.
2
Metabolic interactions: how gut microbial metabolites influence colorectal cancer.代谢相互作用:肠道微生物代谢产物如何影响结直肠癌
Front Microbiol. 2025 Jul 23;16:1611698. doi: 10.3389/fmicb.2025.1611698. eCollection 2025.
3
Study protocol: the 'Endoscope CRC' cohort, a prospective biobank study on the development and evaluation of diagnostic and prognostic biomarker profiles for colorectal cancer and premalignant lesions.

本文引用的文献

1
Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.利用呼气中的挥发性有机化合物检测结直肠腺瘤和癌症:改善筛查的原理验证研究。
Clin Transl Gastroenterol. 2022 Nov 1;13(11):e00518. doi: 10.14309/ctg.0000000000000518.
2
First Breathalyzer Test to Diagnose COVID-19.首次用于诊断新冠肺炎的呼气酒精含量测试仪测试
JAMA. 2022 May 17;327(19):1860. doi: 10.1001/jama.2022.7700.
3
What we know about protein gut metabolites: Implications and insights for human health and diseases.
研究方案:“内镜结直肠癌”队列研究,一项关于结直肠癌及癌前病变诊断和预后生物标志物谱的开发与评估的前瞻性生物样本库研究。
BMJ Open. 2024 Nov 14;14(11):e083229. doi: 10.1136/bmjopen-2023-083229.
4
High-quality identification of volatile organic compounds (VOCs) originating from breath.高质量识别源自呼吸的挥发性有机化合物 (VOCs)。
Metabolomics. 2024 Sep 6;20(5):102. doi: 10.1007/s11306-024-02163-6.
5
Prospect and Challenges of Volatile Organic Compound Breath Testing in Non-Cancer Gastrointestinal Disorders.挥发性有机化合物呼气检测在非癌性胃肠疾病中的前景与挑战
Biomedicines. 2024 Aug 9;12(8):1815. doi: 10.3390/biomedicines12081815.
6
Postbiotics as Adjuvant Therapy in Cancer Care.后生元作为癌症治疗的辅助疗法。
Nutrients. 2024 Jul 24;16(15):2400. doi: 10.3390/nu16152400.
7
Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.呼出气挥发性代谢物生物标志物平台的研究进展与挑战
Metabolomics. 2024 Jul 8;20(4):72. doi: 10.1007/s11306-024-02142-x.
8
The Potential of Fecal Volatile Organic Compound Analysis for the Early Diagnosis of Late-Onset Sepsis in Preterm Infants: A Narrative Review.粪便挥发性有机化合物分析在早产儿晚发性败血症早期诊断中的潜力:一项叙述性综述。
Sensors (Basel). 2024 May 16;24(10):3162. doi: 10.3390/s24103162.
9
Gut Microbiota and Colorectal Cancer: An Umbrella Review of Methodological Trends and Clinical Correlations.肠道微生物群与结直肠癌:方法学趋势和临床相关性的综合综述
Cureus. 2024 Feb 14;16(2):e54210. doi: 10.7759/cureus.54210. eCollection 2024 Feb.
10
Breath Fingerprint of Colorectal Cancer Patients Based on the Gas Chromatography-Mass Spectrometry Analysis.基于气相色谱-质谱分析的结直肠癌患者呼吸指纹图谱
Int J Mol Sci. 2024 Jan 29;25(3):1632. doi: 10.3390/ijms25031632.
我们对蛋白质肠道代谢产物的了解:对人类健康和疾病的影响与见解。
Food Chem X. 2021 Dec 22;13:100195. doi: 10.1016/j.fochx.2021.100195. eCollection 2022 Mar 30.
4
Environmental factors shaping the gut microbiome in a Dutch population.塑造荷兰人群肠道微生物群的环境因素
Nature. 2022 Apr;604(7907):732-739. doi: 10.1038/s41586-022-04567-7. Epub 2022 Apr 13.
5
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
6
Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health.膳食宏量营养素与肠道微生物组:改善心血管代谢健康的精准营养方法。
Gut. 2022 Jun;71(6):1214-1226. doi: 10.1136/gutjnl-2020-323715. Epub 2022 Feb 8.
7
Association between Fecal Short-Chain Fatty Acid Levels, Diet, and Body Mass Index in Patients with Inflammatory Bowel Disease.炎症性肠病患者粪便短链脂肪酸水平、饮食与体重指数之间的关联
Biology (Basel). 2022 Jan 10;11(1):108. doi: 10.3390/biology11010108.
8
Gut microbiome and its role in colorectal cancer.肠道微生物组及其在结直肠癌中的作用。
BMC Cancer. 2021 Dec 11;21(1):1325. doi: 10.1186/s12885-021-09054-2.
9
Association of circulating short chain fatty acid levels with colorectal adenomas and colorectal cancer.循环短链脂肪酸水平与结直肠腺瘤和结直肠癌的关系。
Clin Nutr ESPEN. 2021 Dec;46:297-304. doi: 10.1016/j.clnesp.2021.09.740. Epub 2021 Oct 5.
10
Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer.基于非靶向气相色谱-质谱联用技术的代谢组学用于结直肠癌的早期检测
Front Oncol. 2021 Nov 4;11:729512. doi: 10.3389/fonc.2021.729512. eCollection 2021.